EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In situ nasal gel loaded with Lactoferrin-Coated Brexpiprazole nanostructured lipid carriers for Schizophrenia: Cross-Species validation in Ketamine-Induced rat and zebrafish models

Jaimini Parmar, Nehangi Patel, Alkesh Patel, Nimeet Desai, Pranav Shah

European Journal of Pharmaceutics and Biopharmaceutics · 2026

DOI: 10.1016/j.ejpb.2026.115131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Jaimini Parmar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics & Pharmaceutical Technology, Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Gopal Vidyanagar, Bardoli-M…. Hauptthemen laut MEDLINE: Drug Carriers, Lactoferrin, Schizophrenia, Nanostructures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uka Tarsadia University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brexpiprazole (BXP), a third-generation antipsychotic, exhibits limited brain delivery following oral administration due to first-pass metabolism and blood-brain barrier constraints. To overcome these limitations, a Lactoferrin (Lf)-functionalized BXP-loaded nanostructured lipid carrier (Lf-BXP-NLC) incorporated into a thermoresponsive in situ nasal gel was developed to enable sustained and receptor-mediated nose-to-brain transport. The optimized formulation demonstrated nanoscale particle size (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersLactoferrinSchizophreniaNanostructuresAntipsychotic AgentsAnimalsAdministration, IntranasalRatsLipidsMaleZebrafishKetamineGelsRats, Sprague-DawleyDisease Models, AnimalBlood-Brain BarrierDrug LiberationBrainParticle SizeNasal Mucosa

Stichwörter der Autor:innen

Intranasal deliveryLactoferrin targetingNanostructured lipid carriersNose-to-brain transportSchizophrenia

Substanzen

Drug CarriersLactoferrinLipidsKetamineGelsAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutics & Pharmaceutical Technology, Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Gopal Vidyanagar, Bardoli-Mahuva Road, Tarsadia, Surat, Gujarat 394350, India; Department of Phar…
  • Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Education Campus, Changa, Pelted, Anand, Gujarat 388421, India.
  • Institute of Life Course and Medical Sciences, University of Liverpool, 6 West Derby Street, Liverpool L7 8TX, UK. Electronic address: Nimeet.Desai@liverpool.ac.uk.

Förderung

  • Uka Tarsadia University

Zitieren

APA

Parmar, J., Patel, N., Patel, A., Desai, N., & Shah, P. (2026). In situ nasal gel loaded with Lactoferrin-Coated Brexpiprazole nanostructured lipid carriers for Schizophrenia: Cross-Species validation in Ketamine-Induced rat and zebrafish models. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115131

Vancouver

Parmar J, Patel N, Patel A, Desai N, Shah P. In situ nasal gel loaded with Lactoferrin-Coated Brexpiprazole nanostructured lipid carriers for Schizophrenia: Cross-Species validation in Ketamine-Induced rat and zebrafish models. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115131

BibTeX
@article{Parmar2026,
  author = {Parmar, Jaimini and Patel, Nehangi and Patel, Alkesh and Desai, Nimeet and Shah, Pranav},
  title = {In situ nasal gel loaded with Lactoferrin-Coated Brexpiprazole nanostructured lipid carriers for Schizophrenia: Cross-Species validation in Ketamine-Induced rat and zebrafish models},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  doi = {10.1016/j.ejpb.2026.115131}
}
Kostenlos starten →